D-0551-2026 Class III Ongoing

Recalled by AbbVie Inc. — North Chicago, IL

FDA drug recall D-0551-2026 was initiated by AbbVie Inc. on May 18, 2026 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is ongoing. Affected quantity: 2,736 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 3, 2026
Initiation Date
May 18, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,736 bottles

Product description

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Reason for recall

Failed Stability Specifications

Distribution pattern

US Nationwide.

Code information

Lot # 402805, 407596, Exp Date: 08/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0551-2026
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0551-2026. Report a data issue: hello@regdatalab.com.